Checking Out Checking In: The Development and Validation of an Electronic Screening Tool for Pediatric Psychosocial Distress
2 other identifiers
observational
178
1 country
4
Brief Summary
Background: \- Medical problems and treatments can cause stress in some people. Researchers want to learn more about how to measure distress in young people with medical illnesses. A screening tool called Checking In will be developed in order to help researchers find ways to identify concerns and stresses common to this group. Objective: \- To create a screening tool that will help health care providers identify psychological and social distress in young people with serious illnesses. Eligibility: \- Outpatient youth ages 8 21 who are enrolled on a research protocol at the NIH at the time of the study. Design:
- Phase 1 participants will complete a paper-and-pencil version of Checking In. It asks about mood, pain, fatigue, peer relationships, and sleep. During this phase, participants will be asked about the wording of the questions in Checking In. They will also talk about what they thought of the questions and if they understood them.
- Phase 2 will not involve participant enrollment. During this phase the researchers will be working with technologists to develop the software for an electronic version of Checking In.
- Phase 3 participants will complete an electronic version of Checking In. Researchers will ask questions about the ease or difficulty of using an electronic screen.
- Phase 4 participants and one of their caregivers will complete an electronic version of Checking In. They will also complete other questionnaires related to mood, pain fatigue, peer relationships and sleep. They will be asked their thoughts about using Checking In. On the same day, their NIH doctor will get summary data about their questionnaire answers. The doctor will also provide feedback about the summary form.
- Researchers will compare data from Checking In with data from the other questionnaires.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Apr 2015
Longer than P75 for all trials
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 14, 2015
CompletedFirst Submitted
Initial submission to the registry
April 18, 2015
CompletedFirst Posted
Study publicly available on registry
April 22, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 10, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
November 10, 2021
CompletedMay 31, 2025
May 1, 2025
6.6 years
April 18, 2015
May 30, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Positive score on depression, anxiety, pain and fatigue measures
Positive score on depression, anxiety, pain and fatigue measures
Ongoing
Study Arms (2)
Caregivers
caregivers of pediatric patients with cancer and other serious illnesses
pediatric patients
pediatric patients with cancer and other serious illnesses
Eligibility Criteria
pediatric cancer patients
You may qualify if:
- Age 8 to 21 years.
- Must be enrolled in a research protocol at the NIH or receiving cancer treatment or follow-up care at Johns Hopkins, Children s Hospital Colorado, or Levine Children s Hospital and be an outpatient at time of study. The treatment protocol PI will be contacted before a patient is approached to ensure that the patient is appropriate for enrollment into this protocol.
- Must have a parent/guardian available to complete the study measures.
- Patients and caregiver must be be able to read in English and write in English (as all instruments have not been validated in other languages)
- \<TAB\>
You may not qualify if:
- Patients can be excluded from this study if there is a presence of psychotic symptoms or cognitive impairment, which in the judgment of the Principal or Associate Investigator, or consulting psychiatrist would compromise the patient s ability to accurately complete the measures.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (4)
Children's Hospital Colorado
Aurora, Colorado, 80045, United States
Johns Hopkins University
Baltimore, Maryland, 21218, United States
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States
Carolinas Medical Center Levine Children's Hospital
Charlotte, North Carolina, 28203, United States
Related Links
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
Maryland Pao, M.D.
National Institute of Mental Health (NIMH)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- NIH
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 18, 2015
First Posted
April 22, 2015
Study Start
April 14, 2015
Primary Completion
November 10, 2021
Study Completion
November 10, 2021
Last Updated
May 31, 2025
Record last verified: 2025-05